Use: In combination with a reduced calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in patients with obesity Renal Dose Adjustments Renal dysfunction: Ozempic (injection and tablets) and Rybelsus tablets: No adjustment recommended Wegovy (injection and tablets): Data not available Liver Dose Adjustments Liver dysfunction: Ozempic (injection and tablets) and Rybelsus tablets: No adjustment recommended Wegovy (injection and tablets): Data not available Dose Adjustments ADULT PATIENTS: Switching Between Ozempic and Rybelsus Tablets: Do not switch between Ozempic and Rybelsus tablets during the initiation phase (days 1 to 30)
However, these medications can cause drowsiness, dry mouth, and occasionally constipation
current evidence supports long-term use, as weight regain and metabolic deterioration typically occur upon discontinuation
These include pancreatitis, gallbladder issues, kidney problems, allergic reactions, or changes in vision for diabetic patients
Oral semaglutide drops can help patients lose weight, though results are generally more moderate compared with injectable forms due to differences in dosing and absorption
